Results 181 to 190 of about 119,637 (295)

TRYPTOPHANE METABOLISM

Journal of Biological Chemistry, 1942
Raymond Borchers, Clarence P. Berg, Newton E. Whitman   +2 more
openaire   +1 more source

Metabolism of Tryptophan in Rheumatoid Arthritis [PDF]

Annals of the Rheumatic Diseases, 1962
openaire   +2 more sources

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis. [PDF]

Inflammation
Wu Y, Levy AL, Hermanson P, Janappareddi A, Wang T, Gonzalez-Chapa JA, Shi J, Shenoi S, Li M, Zeng X, Lood C.   +10 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Tryptophan Metabolism in Neurodevelopment and Its Implications For Neurodevelopmental Disorders. [PDF]

Mol Neurobiol
Giuliano MG, Tognini P.
europepmc   +1 more source

A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy

BMEMat, EarlyView.
ZIF‐8‐based nanoparticles co‐delivering CB‐839 (glutaminase inhibitor) and 1‐MT (IDO1 inhibitor), dual‐targeting glutamine/tryptophan metabolism to induce immunogenic cell death, activate STING, block kynurenine production, reverse immunosuppression, and enhance cancer immunotherapy to suppress primary/distant tumors.
Wenli Ning, Yunhan Sun, Mingyang Li, Shilu Liu, Fangjie Yi, Hongfei Wang, Ruibing Bai, Dongdong Liu, Fen Zhao, Guiqiang Zhang, Xiao Fu   +10 more
wiley   +1 more source

Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives. [PDF]

Front Oncol
Yan J, Qian L, Chen S, Karekad MMA, Wu X, Xu M, Xu X.   +6 more
europepmc   +1 more source

Protein hydrolysates in cell culture: Toward multi‐omics characterization

Biotechnology Progress, EarlyView.
While protein hydrolysates are widely used in cell culture applications, they remain undefined and variable products. Multi‐omic characterization evaluating composition and function can transition hydrolysates toward semi‐defined media components.
Michelle Combe, Brandon M. Wrage, Angel Varela‐Rohena, Stanislav Sokolenko   +3 more
wiley   +1 more source

Circadian tryptophan metabolism contributes to systemic aryl hydrocarbon receptor activity. [PDF]

iScience
Morgan EW, Murray IA, Coslo DM, Patterson AD, Perdew GH.   +4 more
europepmc   +1 more source